Clinical Trial Update: A Clinical Study to Evaluate the Efficacy and Safety of Subcutaneous JS005 Injection in the Treatment of Adults With Moderate to Severe Chronic Plaque Psoriasis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of subcutaneous JS005 in adults with moderate to severe chronic plaque psoriasis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• JS005

Snippet

Sponsor: Shanghai Junshi Bioscience Co., Ltd. | Conditions: Moderate to Severe Chronic Plaque Psoriasis | Phase 3 | Status: COMPLETED